Carotenoid Supplements for Children's Cognitive Function and Achievement
Trial Summary
What is the purpose of this trial?
This trial tests if carotenoid supplements can improve cognitive function and academic achievement in pre-adolescent children by protecting brain cells and supporting memory and learning. Carotenoids have been studied for their potential benefits on cognitive function due to their antioxidant properties.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have taken lutein supplements in the past 6 months, except for multivitamins with less than 1 mg of lutein per day.
What evidence supports the effectiveness of the treatment for improving children's cognitive function and achievement?
Research suggests that lutein and zeaxanthin, which are part of the treatment, are linked to better cognitive function in children, as they accumulate in the brain and may enhance memory and attention. Studies have shown that higher levels of these carotenoids in the body are associated with improved cognitive abilities, such as executive processes and intellectual ability, in children.12345
Is it safe for children to take carotenoid supplements like lutein and zeaxanthin?
How is the carotenoid supplement treatment different from other treatments for improving children's cognitive function?
The carotenoid supplement, containing lutein and zeaxanthin, is unique because it targets cognitive function by accumulating in neural tissue, potentially enhancing memory and academic abilities in children. Unlike other treatments, it specifically focuses on increasing macular carotenoids, which are linked to cognitive improvements, and is being tested in a structured 9-month trial to assess its impact on children's cognitive development.12347
Research Team
Naiman Khan, PhD
Principal Investigator
University of Illinois Urbana-Champaign
Eligibility Criteria
This trial is for children aged 8-10 with normal or corrected vision and no recent lutein supplementation. They must not have a learning disability, be in early puberty (Tanner scale ≤2), and have both child assent and parent/guardian consent.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a carotenoid supplement or placebo daily for 9 months
Follow-up
Participants are monitored for changes in cognitive function and academic achievement
Treatment Details
Interventions
- Active supplement (Carotenoid Supplement)
- Placebo control (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Urbana-Champaign
Lead Sponsor
Chris Harlan
University of Illinois at Urbana-Champaign
Chief Executive Officer since 2019
MBA from the University of Illinois at Urbana-Champaign
Eric Minor
University of Illinois at Urbana-Champaign
Chief Marketing Officer since 2019
Bachelor’s degree in Electrical Engineering from the University of Illinois and MBA from the University of Chicago
Northeastern University
Collaborator
Jared Auclair
Northeastern University
Chief Executive Officer
PhD in Biomedical Science from the University of Massachusetts Medical School
Anantdeep Kaur
Northeastern University
Chief Medical Officer since 2023
Master’s and Doctorate in Biotechnology from the University of Technology Sydney
University of Georgia
Collaborator
Dr. Biao He
University of Georgia
Chief Executive Officer
PhD in Veterinary Medicine
Dr. Hank Radziewicz
University of Georgia
Chief Medical Officer
MD from Duke University, MSCR from Emory University